Antibody, also called immunoglobulin, a protective protein produced by the immune system in response to the presence of a foreign substance, called an antigen. Antibodies recognize and latch onto antigens in order to remove them from the body. A wide range of substances are regarded by the body as antigens, including disease-causing organisms and toxic materials such as insect venom.
Treatment that uses antibodies to help the body fight cancer, infection, or other diseases. Antibodies are proteins made by the immune system that bind to specific markers on cells or tissues. IgG1 antibodies are a type of antibody made in the laboratory that can be used in diagnosis or treatment. In cancer treatment, IgG1 antibodies may kill cancer cells directly, they may block development of tumor blood vessels, or they may help the immune system kill cancer cells.
This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Therapy. This report contains market size and forecasts of Monoclonal Antibody Therapy in global, including the following market information:
Global Monoclonal Antibody Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Monoclonal Antibody Therapy market was valued at US$ 117490 million in 2022 and is projected to reach US$ 186150 million by 2029, at a CAGR of 6.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Roche, Abbvie and J & J, with revenues of 15.61%, 12.10% and 10.05% in 2019.
We surveyed the Monoclonal Antibody Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monoclonal Antibody Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Monoclonal Antibody Therapy Market Segment Percentages, by Type, 2022 (%)
Human Monoclonal Antibody
Humanized Monoclonal Antibody
Chimeric Monoclonal Antibody
Murine Monoclonal Antibody
Global Monoclonal Antibody Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Monoclonal Antibody Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Autoimmune Diseases
Others
Global Monoclonal Antibody Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Monoclonal Antibody Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monoclonal Antibody Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Monoclonal Antibody Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
Roche
Johson & Johson
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monoclonal Antibody Therapy, market overview.
Chapter 2: Global Monoclonal Antibody Therapy market size in revenue.
Chapter 3: Detailed analysis of Monoclonal Antibody Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monoclonal Antibody Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Monoclonal Antibody Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monoclonal Antibody Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monoclonal Antibody Therapy Overall Market Size
2.1 Global Monoclonal Antibody Therapy Market Size: 2022 VS 2029
2.2 Global Monoclonal Antibody Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monoclonal Antibody Therapy Players in Global Market
3.2 Top Global Monoclonal Antibody Therapy Companies Ranked by Revenue
3.3 Global Monoclonal Antibody Therapy Revenue by Companies
3.4 Top 3 and Top 5 Monoclonal Antibody Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Monoclonal Antibody Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monoclonal Antibody Therapy Players in Global Market
3.6.1 List of Global Tier 1 Monoclonal Antibody Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Monoclonal Antibody Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Monoclonal Antibody Therapy Market Size Markets, 2022 & 2029
4.1.2 Human Monoclonal Antibody
4.1.3 Humanized Monoclonal Antibody
4.1.4 Chimeric Monoclonal Antibody
4.1.5 Murine Monoclonal Antibody
4.2 By Type - Global Monoclonal Antibody Therapy Revenue & Forecasts
4.2.1 By Type - Global Monoclonal Antibody Therapy Revenue, 2018-2023
4.2.2 By Type - Global Monoclonal Antibody Therapy Revenue, 2024-2029
4.2.3 By Type - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Monoclonal Antibody Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Autoimmune Diseases
5.1.4 Others
5.2 By Application - Global Monoclonal Antibody Therapy Revenue & Forecasts
5.2.1 By Application - Global Monoclonal Antibody Therapy Revenue, 2018-2023
5.2.2 By Application - Global Monoclonal Antibody Therapy Revenue, 2024-2029
5.2.3 By Application - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Monoclonal Antibody Therapy Market Size, 2022 & 2029
6.2 By Region - Global Monoclonal Antibody Therapy Revenue & Forecasts
6.2.1 By Region - Global Monoclonal Antibody Therapy Revenue, 2018-2023
6.2.2 By Region - Global Monoclonal Antibody Therapy Revenue, 2024-2029
6.2.3 By Region - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Monoclonal Antibody Therapy Revenue, 2018-2029
6.3.2 US Monoclonal Antibody Therapy Market Size, 2018-2029
6.3.3 Canada Monoclonal Antibody Therapy Market Size, 2018-2029
6.3.4 Mexico Monoclonal Antibody Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Monoclonal Antibody Therapy Revenue, 2018-2029
6.4.2 Germany Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.3 France Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.4 U.K. Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.5 Italy Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.6 Russia Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Monoclonal Antibody Therapy Market Size, 2018-2029
6.4.8 Benelux Monoclonal Antibody Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Monoclonal Antibody Therapy Revenue, 2018-2029
6.5.2 China Monoclonal Antibody Therapy Market Size, 2018-2029
6.5.3 Japan Monoclonal Antibody Therapy Market Size, 2018-2029
6.5.4 South Korea Monoclonal Antibody Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Monoclonal Antibody Therapy Market Size, 2018-2029
6.5.6 India Monoclonal Antibody Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Monoclonal Antibody Therapy Revenue, 2018-2029
6.6.2 Brazil Monoclonal Antibody Therapy Market Size, 2018-2029
6.6.3 Argentina Monoclonal Antibody Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Monoclonal Antibody Therapy Revenue, 2018-2029
6.7.2 Turkey Monoclonal Antibody Therapy Market Size, 2018-2029
6.7.3 Israel Monoclonal Antibody Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Monoclonal Antibody Therapy Market Size, 2018-2029
6.7.5 UAE Monoclonal Antibody Therapy Market Size, 2018-2029
7 Monoclonal Antibody Therapy Companies Profiles
7.1 Abbvie
7.1.1 Abbvie Company Summary
7.1.2 Abbvie Business Overview
7.1.3 Abbvie Monoclonal Antibody Therapy Major Product Offerings
7.1.4 Abbvie Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.1.5 Abbvie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Monoclonal Antibody Therapy Major Product Offerings
7.2.4 Amgen Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Glaxosmithkline
7.3.1 Glaxosmithkline Company Summary
7.3.2 Glaxosmithkline Business Overview
7.3.3 Glaxosmithkline Monoclonal Antibody Therapy Major Product Offerings
7.3.4 Glaxosmithkline Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.3.5 Glaxosmithkline Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Monoclonal Antibody Therapy Major Product Offerings
7.4.4 Merck Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Monoclonal Antibody Therapy Major Product Offerings
7.5.4 Novartis Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Monoclonal Antibody Therapy Major Product Offerings
7.6.4 Roche Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Johson & Johson
7.7.1 Johson & Johson Company Summary
7.7.2 Johson & Johson Business Overview
7.7.3 Johson & Johson Monoclonal Antibody Therapy Major Product Offerings
7.7.4 Johson & Johson Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.7.5 Johson & Johson Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Monoclonal Antibody Therapy Major Product Offerings
7.8.4 Novartis Monoclonal Antibody Therapy Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Monoclonal Antibody Therapy Market Opportunities & Trends in Global Market
Table 2. Monoclonal Antibody Therapy Market Drivers in Global Market
Table 3. Monoclonal Antibody Therapy Market Restraints in Global Market
Table 4. Key Players of Monoclonal Antibody Therapy in Global Market
Table 5. Top Monoclonal Antibody Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Monoclonal Antibody Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Monoclonal Antibody Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Monoclonal Antibody Therapy Product Type
Table 9. List of Global Tier 1 Monoclonal Antibody Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monoclonal Antibody Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Monoclonal Antibody Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Monoclonal Antibody Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Monoclonal Antibody Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Monoclonal Antibody Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Monoclonal Antibody Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Monoclonal Antibody Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Monoclonal Antibody Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Monoclonal Antibody Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Monoclonal Antibody Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Monoclonal Antibody Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Monoclonal Antibody Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Monoclonal Antibody Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Monoclonal Antibody Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Monoclonal Antibody Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Abbvie Company Summary
Table 31. Abbvie Monoclonal Antibody Therapy Product Offerings
Table 32. Abbvie Monoclonal Antibody Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Abbvie Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Monoclonal Antibody Therapy Product Offerings
Table 36. Amgen Monoclonal Antibody Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. Glaxosmithkline Company Summary
Table 39. Glaxosmithkline Monoclonal Antibody Therapy Product Offerings
Table 40. Glaxosmithkline Monoclonal Antibody Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Glaxosmithkline Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Monoclonal Antibody Therapy Product Offerings
Table 44. Merck Monoclonal Antibody Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Monoclonal Antibody Therapy Product Offerings
Table 48. Novartis Monoclonal Antibody Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Monoclonal Antibody Therapy Product Offerings
Table 52. Roche Monoclonal Antibody Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Johson & Johson Company Summary
Table 55. Johson & Johson Monoclonal Antibody Therapy Product Offerings
Table 56. Johson & Johson Monoclonal Antibody Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Johson & Johson Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Monoclonal Antibody Therapy Product Offerings
Table 60. Novartis Monoclonal Antibody Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
List of Figures
Figure 1. Monoclonal Antibody Therapy Segment by Type in 2022
Figure 2. Monoclonal Antibody Therapy Segment by Application in 2022
Figure 3. Global Monoclonal Antibody Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Monoclonal Antibody Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Monoclonal Antibody Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Monoclonal Antibody Therapy Revenue in 2022
Figure 8. By Type - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Monoclonal Antibody Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Monoclonal Antibody Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 16. US Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 28. China Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Monoclonal Antibody Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Monoclonal Antibody Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Abbvie Monoclonal Antibody Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Monoclonal Antibody Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Glaxosmithkline Monoclonal Antibody Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Monoclonal Antibody Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Monoclonal Antibody Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roche Monoclonal Antibody Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johson & Johson Monoclonal Antibody Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Monoclonal Antibody Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
